It's the most-searched question about this provider, so here's the straight answer
Concentration mix-ups are the most common dosing error in FAERS for compounded tirzepatide
Although the company discourages using the vial for multi-dosing (it doesnt contain a preservative), one option would be to inject 1 mg (0.05 mL) weekly for 2 weeks, 2 mg (0.1 mL) weekly for 2 weeks, then 4 mg (0.2 ml) weekly
When inspections do occur and violations are found, the enforcement process can be slow
Common ones include: Nausea, diarrhea, constipation, vomiting, and abdominal pain
Aside from prompting increased insulin production to lower blood sugar in diabetes treatment, higher GLP-1 levels interact with brain areas that regulate appetite and satiety